Full-service marketing for peptide and NAD clinics.
The PCAC ruling rewrote what you can advertise — we've already adapted the playbook.
Real intent. Real cities. Ranked, cited, and compliant.
A sample of live queries we own for peptide therapy clinics, NAD+ providers, and regenerative medicine practices. Every page built after the PCAC ruling.
Three things killing your pipeline after the PCAC ruling.
FDA's PCAC ruling changed which peptides you can market.
Generic agencies are still writing pre-2026 copy. Google flags it. The PCAC ruling redefined which compounds you can name, which claims you can make, and which page structures survive the policy classifier. If your site hasn't been rewritten, you're running on borrowed time.
NAD+ is no longer niche — it's competitive.
Six years ago NAD+ IV was a biohacker's secret. Now every longevity clinic and med spa offers it. The differentiator isn't the protocol — it's whether patients find you when they search. Search visibility is the only moat that compounds.
AI assistants won't cite you if your site mixes compliant and non-compliant claims.
Even one wrong phrase can drop you from ChatGPT's response set. AI engines evaluate the entire domain, not just the page. If your peptide pages contain claims the PCAC ruling invalidated, your compliant content gets dragged down too.
One engagement. Five pillars built for post-PCAC peptide marketing.
Post-PCAC peptide page architecture
We know which compounds you can name and which you can't. Separate pages per compliant peptide, structured within the new regulatory guardrails. Updated the week the ruling dropped.
NAD+ IV and oral protocol pages
Dedicated content for NAD+ IV drips and oral protocols — mechanism, dosing, citation-grade sourcing. Built for E-E-A-T signals Google and AI engines trust.
Mechanism + dosing + citation content
Primary-source links, clinical references, and mechanism-of-action depth that passes Google's medical-authority threshold. We don't fake citations.
AI citation strategy
Get named when patients ask AI 'best peptide clinic in [city]' or 'NAD+ therapy near me.' The citation architecture that puts you in the response set.
Compliance audit of existing pages
Before we write anything new, we redline what needs removing. A full audit of your current peptide and NAD+ content against the PCAC ruling — delivered as a standalone deliverable.
Three commitments generalist agencies can't make.
PCAC-current.
We rewrote our playbook the week the ruling dropped. While other agencies are still running pre-2026 templates, every page we ship reflects the current regulatory landscape. Read our analysis: /blog/fda-pcac-peptide-ruling-july-2026.
Citation depth.
Peptides need primary-source links Google trusts. We don't fabricate references or link to aggregator sites. Every citation is traceable to a peer-reviewed source or regulatory document.
Compliance audit included.
Before we write a single new page, we audit your existing content and tell you what to remove. The audit is a standalone deliverable — even if you don't hire us for the build.
Three phases. Built for peptide clinics. Every step shows its work.
Nexus Regenerative went from flagged to first page in 45 days.
Nexus Regenerative, Scottsdale
Post-PCAC page rebuild replaced 12 non-compliant peptide pages with compliant architecture. First-page rankings in 45 days, AI citations in 60.
Drip & Recover, Miami
NAD+ IV and oral protocol pages with mechanism-level sourcing. Ranked for 'NAD+ drip Miami' and cited in Perplexity within one quarter.
Pinnacle Longevity, Dallas
Full compliance audit removed 8 flagged claims, then rebuilt peptide and NAD+ pages to current standards. Organic consults up 90% in 6 months.